Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network

被引：0

作者：

Rose, Angela M. C. ^{[1
]}

Pozo, Francisco ^{[2
,3
]}

Martinez-Baz, Ivan ^{[3
,4
]}

Mazagatos, Clara ^{[3
,5
]}

Bossuyt, Nathalie ^{[6
]}

Cauchi, John Paul ^{[7
]}

Petrovic, Goranka ^{[8
]}

Loghin, Isabela I. ^{[9
]}

Vaikutyte, Roberta ^{[10
]}

Buda, Silke ^{[11
]}

Machado, Ausenda ^{[12
]}

Duffy, Roisin ^{[13
]}

Oroszi, Beatrix ^{[14
]}

Howard, Jennifer ^{[1
]}

Echeverria, Aitziber ^{[3
,4
]}

Andreu, Cristina ^{[15
]}

Barbezange, Cyril ^{[6
]}

Dziugyte, Ausra ^{[7
]}

Nonkovic, Diana ^{[16
]}

Popescu, Corneliu-Petru ^{[17
]}

Majauskaite, Fausta ^{[18
]}

Tolksdorf, Kristin ^{[11
]}

Gomez, Veronica ^{[12
]}

Domegan, Lisa ^{[13
]}

Horvath, Judit Krisztina ^{[14
]}

Castilla, Jesus ^{[3
,4
]}

Garcia, Miriam ^{[19
]}

Demuyser, Thomas ^{[20
]}

Borg, Maria-Louise ^{[7
]}

Tabain, Irena ^{[8
]}

Lazar, Mihaela ^{[21
]}

Kubiliute, Ieva ^{[18
]}

Duerrwald, Ralf ^{[11
]}

Guiomar, Raquel ^{[12
]}

O'Donnell, Joan ^{[13
]}

Kristof, Katalin ^{[14
]}

Nicolay, Nathalie ^{[22
]}

Bacci, Sabrina ^{[22
]}

Kissling, Esther ^{[1
]}

机构：

[1] Epiconcept, Paris, France

[2] Inst Hlth Carlos III, Natl Ctr Microbiol, Madrid, Spain

[3] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain

[4] Inst Salud Publ Navarra IdiSNA, Pamplona, Spain

[5] Inst Hlth Carlos III, Natl Ctr Epidemiol, Madrid, Spain

[6] Sciensano, Brussels, Belgium

[7] Dept Hlth Regulat Hlth Promot & Dis Prevent, Msida, Malta

[8] Croatian Inst Publ Hlth, Zagreb, Croatia

[9] St Parascheva Clin Hosp Infect Dis, Iasi, Romania

[10] Lithuanian Univ Hlth Sci, Kaunas, Lithuania

[11] Robert Koch Inst, Berlin, Germany

[12] Natl Inst Hlth Dr Ricardo Jorge, Lisbon, Portugal

[13] Hlth Serv Execut Hlth Protect Surveillance Ctr, Dublin, Ireland

[14] Semmelweis Univ, Budapest, Hungary

[15] Serv Extremeno Salud, Subdirecc Epidemiol, Direcc Gen Salud Publ, Merida, Spain

[16] Teaching Publ Hlth Inst Split Dalmatia Cty, Split, Croatia

[17] Dr Victor Babes Clin Hosp Infect & Trop Dis, Bucharest, Romania

[18] Vilnius Univ, Inst Clin Med, Med Fac, Vilnius, Lithuania

[19] Dept San, Dept Sanidad, Gobierno Aragon, Zaragoza, Spain

[20] Dept Microbiol & Infect control, Dept Microbiol & Infect Control, Brussels, Belgium

[21] Cantacuzino Natl Mil Med Inst Res & Dev, Bucharest, Romania

[22] European Ctr Dis Prevent & Control, Stockholm, Sweden

来源：

INFLUENZA AND OTHER RESPIRATORY VIRUSES | 2024年 / 18卷 / 02期

关键词：

hospital; influenza; SARI patients; test-negative design; vaccine effectiveness;

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We conducted a multicentre hospital-based test-negative case-control study to measure vaccine effectiveness (VE) against PCR-confirmed influenza in adult patients with severe acute respiratory infection (SARI) during the 2022/2023 influenza season in Europe. Among 5547 SARI patients >= 18 years, 2963 (53%) were vaccinated against influenza. Overall VE against influenza A(H1N1)pdm09 was 11% (95% CI: -23-36); 20% (95% CI: -4-39) against A(H3N2) and 56% (95% CI: 22-75) against B. During the 2022/2023 season, while VE against hospitalisation with influenza B was >55%, it was <= 20% for influenza A subtypes. While influenza vaccination should be a priority for future seasons, improved vaccines against influenza are needed.

引用

页数：9

共 50 条

[1] Moderate influenza vaccine effectiveness against influenza A(H1N1)pdm09 virus and low effectiveness against A(H3N2) virus among older adults during 2013-2014 influenza season in Beijing, China
Zhang, Li
Pan, Yang
Ma, Chunna
Duan, Wei
Sun, Ying
Wu, Shuangsheng
Zhang, Man
Tian, Yi
Zheng, Yang
Yang, Peng
Wang, Quanyi
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (06) : 1323 - 1330
[2] 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals
Rondy, M.
Launay, O.
Puig-Barbera, J.
Gefenaite, G.
Castilla, J.
Donati, K. de Gaetano
Galtier, F.
Hak, E.
Guevara, M.
Costanzo, S.
Moren, A.
EUROSURVEILLANCE, 2015, 20 (02) : 9 - 20
[3] Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016-17 and 2017-18)
Kissling, Esther
Pozo, Francisco
Buda, Silke
Vilcu, Ana-Maria
Rizzo, Caterina
Gherasim, Alin
Horvath, Judit Krisztina
Brytting, Mia
Domegan, Lisa
Meijer, Adam
Paradowska-Stankiewicz, Iwona
Machado, Ausenda
Vucina, Vesna Visekruna
Lazar, Mihaela
Johansen, Kari
Durrwald, Ralf
van der Werf, Sylvie
Bella, Antonino
Larrauri, Amparo
Ferenczi, Annamaria
Zakikhany, Katherina
O'Donnell, Joan
Dijkstra, Frederika
Bogusz, Joanna
Guiomar, Raquel
Filipovic, Sanja Kurecic
Pitigoi, Daniela
Penttinen, Pasi
Valenciano, Marta
VACCINE: X, 2019, 3
[4] Influenza vaccine effectiveness estimates against influenza A(H3N2) and A(H1N1) pdm09 among children during school-based outbreaks in the 2016-2017 season in Beijing, China
Zhang, Li
van der Hoek, Wim
Krafft, Thomas
Pilot, Eva
van Astenc, Liselotte
Lin, Ge
Wu, Shuangsheng
Duan, Wei
Yang, Peng
Wang, Quanyi
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (04) : 816 - 822
[5] Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network
Rondy, M.
Castilla, J.
Launay, O.
Costanzo, S.
Ezpeleta, C.
Galtier, F.
Donati, K. de Gaetano
Moren, A.
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (05) : 1217 - 1224
[6] Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus
Filipovic, S. Kurecic
Gjenero-Margan, I.
Kissling, E.
Kaic, B.
Cvitkovic, A.
EPIDEMIOLOGY AND INFECTION, 2015, 143 (12) : 2596 - 2603
[7] Evaluation of correlates of protection against influenza A(H3N2) and A (H1N1)pdm09 infection: Applications to the hospitalized patient population
Petrie, Joshua G.
Martin, Emily T.
Truscon, Rachel
Johnson, Emileigh
Cheng, Caroline K.
McSpadden, E. J.
Malosh, Ryan E.
Lauring, Adam S.
Lamerato, Lois E.
Eichelberger, Maryna C.
Ferdinands, Jill M.
Monto, Arnold S.
VACCINE, 2019, 37 (10) : 1284 - 1292
[8] Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway
Bernardo Rafael Guzmán Herrador
Preben Aavitsland
Berit Feiring
Marianne A Riise Bergsaker
Katrine Borgen
BMC Infectious Diseases, 12
[9] Usefulness of health registries when estimating vaccine effectiveness during the influenza A (H1N1)pdm09 pandemic in Norway
Herrador, Bernardo Rafael Guzman
Aavitsland, Preben
Feiring, Berit
Bergsaker, Marianne A. Riise
Borgen, Katrine
BMC INFECTIOUS DISEASES, 2012, 12
[10] Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016
Chambers, C.
Skowronski, D. M.
Sabaiduc, S.
Winter, A. L.
Dickinson, J. A.
De Serres, G.
Gubbay, J. B.
Drews, S. J.
Martineau, C.
Eshaghi, A.
Krajden, M.
Bastien, N.
Li, Y.
EUROSURVEILLANCE, 2016, 21 (11): : 27 - 34

← 1 2 3 4 5 →